Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Give us feedback
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
Detailled Reference
Download
Unpublished conference/Abstract (Scientific congresses and symposiums)
Development of a negative self-vaccine against type 1 diabetes based on central tolerogenic properties of the thymus
Geenen, Vincent
2017
•
Flanders vaccines & BioWin
Permalink
https://hdl.handle.net/2268/232982
Files (1)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
Flanders Vaccines_BioWin.VGeenen.pdf
Author preprint (904.14 kB)
Download
All documents in ORBi are protected by a
user license
.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Keywords :
Type 1 diabetes; Self-vaccine
Research Center/Unit :
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège
Disciplines :
Immunology & infectious disease
Author, co-author :
Geenen, Vincent
;
Université de Liège - ULiège > Centre d'immunologie
Language :
English
Title :
Development of a negative self-vaccine against type 1 diabetes based on central tolerogenic properties of the thymus
Publication date :
17 October 2017
Event name :
Flanders vaccines & BioWin
Event organizer :
Flanders vaccines
Event place :
Ghent, Belgium
Event date :
17 octobre 2017
By request :
Yes
Additional URL :
http://flandersvaccine.be/job/14-fund-of-scientific-research-giga-research-institute/
Name of the research project :
THYDIA
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique
Available on ORBi :
since 16 February 2019
Statistics
Number of views
49 (1 by ULiège)
Number of downloads
21 (0 by ULiège)
More statistics
Bibliography
Similar publications
Contact ORBi